Latest news

Bruno Sangro presenting findings from the CheckMate 040 trial to EASL 2020.Bruno Sangro presenting findings from the CheckMate 040 trial to EASL 2020.

EASL 2020: Treatment for HCC

Immunotherapy combinations show promise for advanced liver cancer.

Professor Heiner Wedemeyer of Essen University Hospital.Professor Heiner Wedemeyer of Essen University Hospital.

EASL 2020: Hepatitis D

Bulevirtide shows promise as maintenance therapy for hepatitis D.

EASL 2020: Hepatitis C elimination

EASL 2020: Hepatitis C elimination

Only one in four high-income countries on track for hepatitis C elimination by 2030.

infohep news